La vacuna de AstraZeneca tiene una eficacia del 79% en un ensayo en EEUU

The findings of a large U.S. trial have shown that the coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100% effective against severe disease and hospitalization.

Fuente: Youtube